CTI BioPharma
CTIC
#5622
Rank
HK$9.32 B
Marketcap
HK$70.74
Share price
0.00%
Change (1 day)
30.79%
Change (1 year)

CTI BioPharma (CTIC) - Cash on Hand

Cash on Hand as of March 2023 : HK$0.45 Billion

According to CTI BioPharma 's latest financial reports the company has HK$0.45 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

CTI BioPharma - Cash on Hand chart (from 1997 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31HK$0.62 B22.39%
2021-12-31HK$0.51 B25.51%
2020-12-31HK$0.40 B55.08%
2019-12-31HK$0.26 B-50.06%
2018-12-31HK$0.52 B55.47%
2017-12-31HK$0.33 B-1.04%
2016-12-31HK$0.34 B-65.66%
2015-12-31HK$0.99 B80.57%
2014-12-31HK$0.55 B-0.96%
2013-12-31HK$0.55 B42.1%
2012-12-31HK$0.39 B6.98%
2011-12-31HK$0.36 B107.34%
2010-12-31HK$0.17 B-39.88%
2009-12-31HK$0.29 B255.54%
2008-12-31HK$82.46 M-42.35%
2007-12-31HK$0.14 B-65.84%
2006-12-31HK$0.41 B-21.6%
2005-12-31HK$0.53 B-40.69%
2004-12-31HK$0.90 B26.85%
2003-12-31HK$0.70 B-35.1%
2002-12-31HK$1.09 B-45.19%
2001-12-31HK$1.99 B65.19%
2000-12-31HK$1.20 B550.69%
1999-12-31HK$0.18 B444.67%
1998-12-31HK$34.08 M-50.57%
1997-12-31HK$68.97 M62.13%
1996-12-31HK$42.54 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
HK$73.49 B 15,905.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$128.41 B 27,864.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
HK$22.79 B 4,864.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
HK$13.43 B 2,824.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$77.14 B 16,699.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$17.14 B 3,633.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
HK$75.89 B 16,427.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland